Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (26)

« Back to Publications

Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatments

Cake C. et al, (2022), Trials, 23

Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial

Dorward J. et al, (2022), British Journal of General Practice, 72, E446 - E455

Change in glomerular filtration rate over time in the Oxford Renal Cohort Study: observational study

Hirst JA. et al, (2022), British Journal of General Practice, 72, E261 - E268

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Yu LM. et al, (2021), Lancet, 398, 843 - 855

Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Butler CC. et al, (2021), The Lancet Respiratory Medicine, 9, 1010 - 1020

Platform Randomised trial of INterventions against COVID-19 in older peoPLE (PRINCIPLE): Protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk

Hayward G. et al, (2021), BMJ Open, 11

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Butler CC. et al, (2021), The Lancet, 397, 1063 - 1074

Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: Randomised controlled trial

McManus RJ. et al, (2021), The BMJ, 372

Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial.

McManus RJ. et al, (2021), BMJ, 372

Prevalence and factors associated with multimorbidity among primary care patients with decreased renal function

HIRST J. et al, (2021), PLoS One

Prevalence and factors associated with multimorbidity among primary care patients with decreased renal function

Hirst JA. et al, (2021), PLoS ONE, 16

Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial

PRINCIPLE Trial Collaborative Group . et al, (2021)

Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial

PRINCIPLE Collaborative Group . et al, (2021)

Using systematic data categorisation to quantify the types of data collected in clinical trials: The DataCat project

Crowley E. et al, (2020), Trials, 21

Primary care treatment of insomnia: Study protocol for a pragmatic, multicentre, randomised controlled trial comparing nurse-delivered sleep restriction therapy to sleep hygiene (the HABIT trial)

Kyle SD. et al, (2020), BMJ Open, 10

Load More